Serotonin transporter gene polymorphisms and treatment-resistant depression

Cristian Bonvicini, Alessandra Minelli, Catia Scassellati, Marco Bortolomasi, Matilde Segala, Riccardo Sartori, Mario Giacopuzzi, Massimo Gennarelli

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Major Depression Disorder (MDD) is a serious mental illness that is one of the most disabling diseases worldwide. In addition, approximately 15% of depression patients are defined treatment-resistant (TRD). Preclinical and genetic studies show that serotonin modulation dysfunction exists in patients with TRD. Some polymorphisms in the promoter region of the serotonin transporter gene (SLC6A4) are likely to be involved in the pathogenesis/treatment of MDD; however, no data are available concerning TRD.Therefore, in order to investigate the possible influence of SLC6A4 polymorphisms on the risk of TRD, we genotyped 310 DSM-IV MDD treatment-resistant patients and 284 healthy volunteers. We analysed the most studied polymorphism 5-HTTLPR (L/S) and a single nucleotide substitution, rs25531 (A/G), in relation to different functional haplotype combinations. However the correct mapping of rs25531 is still debated whether it is within or outside the insertion. Our sequencing analysis showed that rs25531 is immediately outside of the 5-HTTLPR segment.Differences in 5-HTTLPR allele (p=0.04) and in L allele carriers (pALA homozygote haplotype was more represented among the control subjects (p=0.01, OR=0.64 95%CI: 0.45-0.91).In conclusion, this study reports a protective effect of the LALA haplotype on TRD, supporting the hypothesis that lower serotonin transporter transcription alleles are correlated to a common resistant depression mechanism.

Original languageEnglish
Pages (from-to)367-370
Number of pages4
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume34
Issue number6
DOIs
Publication statusPublished - Aug 2010

Fingerprint

Treatment-Resistant Depressive Disorder
Serotonin Plasma Membrane Transport Proteins
Depression
Haplotypes
Alleles
Genes
Homozygote
Genetic Promoter Regions
Diagnostic and Statistical Manual of Mental Disorders
Serotonin
Healthy Volunteers
Nucleotides
Therapeutics

Keywords

  • 5-HTTLPR
  • Rs25531
  • SLC6A4
  • Treatment-resistant depression

ASJC Scopus subject areas

  • Biological Psychiatry
  • Pharmacology

Cite this

Serotonin transporter gene polymorphisms and treatment-resistant depression. / Bonvicini, Cristian; Minelli, Alessandra; Scassellati, Catia; Bortolomasi, Marco; Segala, Matilde; Sartori, Riccardo; Giacopuzzi, Mario; Gennarelli, Massimo.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 34, No. 6, 08.2010, p. 367-370.

Research output: Contribution to journalArticle

Bonvicini, Cristian ; Minelli, Alessandra ; Scassellati, Catia ; Bortolomasi, Marco ; Segala, Matilde ; Sartori, Riccardo ; Giacopuzzi, Mario ; Gennarelli, Massimo. / Serotonin transporter gene polymorphisms and treatment-resistant depression. In: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2010 ; Vol. 34, No. 6. pp. 367-370.
@article{7b1cfe0d37e34aab8803ac35eb1ffd04,
title = "Serotonin transporter gene polymorphisms and treatment-resistant depression",
abstract = "Major Depression Disorder (MDD) is a serious mental illness that is one of the most disabling diseases worldwide. In addition, approximately 15{\%} of depression patients are defined treatment-resistant (TRD). Preclinical and genetic studies show that serotonin modulation dysfunction exists in patients with TRD. Some polymorphisms in the promoter region of the serotonin transporter gene (SLC6A4) are likely to be involved in the pathogenesis/treatment of MDD; however, no data are available concerning TRD.Therefore, in order to investigate the possible influence of SLC6A4 polymorphisms on the risk of TRD, we genotyped 310 DSM-IV MDD treatment-resistant patients and 284 healthy volunteers. We analysed the most studied polymorphism 5-HTTLPR (L/S) and a single nucleotide substitution, rs25531 (A/G), in relation to different functional haplotype combinations. However the correct mapping of rs25531 is still debated whether it is within or outside the insertion. Our sequencing analysis showed that rs25531 is immediately outside of the 5-HTTLPR segment.Differences in 5-HTTLPR allele (p=0.04) and in L allele carriers (pALA homozygote haplotype was more represented among the control subjects (p=0.01, OR=0.64 95{\%}CI: 0.45-0.91).In conclusion, this study reports a protective effect of the LALA haplotype on TRD, supporting the hypothesis that lower serotonin transporter transcription alleles are correlated to a common resistant depression mechanism.",
keywords = "5-HTTLPR, Rs25531, SLC6A4, Treatment-resistant depression",
author = "Cristian Bonvicini and Alessandra Minelli and Catia Scassellati and Marco Bortolomasi and Matilde Segala and Riccardo Sartori and Mario Giacopuzzi and Massimo Gennarelli",
year = "2010",
month = "8",
doi = "10.1016/j.pnpbp.2010.04.020",
language = "English",
volume = "34",
pages = "367--370",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Serotonin transporter gene polymorphisms and treatment-resistant depression

AU - Bonvicini, Cristian

AU - Minelli, Alessandra

AU - Scassellati, Catia

AU - Bortolomasi, Marco

AU - Segala, Matilde

AU - Sartori, Riccardo

AU - Giacopuzzi, Mario

AU - Gennarelli, Massimo

PY - 2010/8

Y1 - 2010/8

N2 - Major Depression Disorder (MDD) is a serious mental illness that is one of the most disabling diseases worldwide. In addition, approximately 15% of depression patients are defined treatment-resistant (TRD). Preclinical and genetic studies show that serotonin modulation dysfunction exists in patients with TRD. Some polymorphisms in the promoter region of the serotonin transporter gene (SLC6A4) are likely to be involved in the pathogenesis/treatment of MDD; however, no data are available concerning TRD.Therefore, in order to investigate the possible influence of SLC6A4 polymorphisms on the risk of TRD, we genotyped 310 DSM-IV MDD treatment-resistant patients and 284 healthy volunteers. We analysed the most studied polymorphism 5-HTTLPR (L/S) and a single nucleotide substitution, rs25531 (A/G), in relation to different functional haplotype combinations. However the correct mapping of rs25531 is still debated whether it is within or outside the insertion. Our sequencing analysis showed that rs25531 is immediately outside of the 5-HTTLPR segment.Differences in 5-HTTLPR allele (p=0.04) and in L allele carriers (pALA homozygote haplotype was more represented among the control subjects (p=0.01, OR=0.64 95%CI: 0.45-0.91).In conclusion, this study reports a protective effect of the LALA haplotype on TRD, supporting the hypothesis that lower serotonin transporter transcription alleles are correlated to a common resistant depression mechanism.

AB - Major Depression Disorder (MDD) is a serious mental illness that is one of the most disabling diseases worldwide. In addition, approximately 15% of depression patients are defined treatment-resistant (TRD). Preclinical and genetic studies show that serotonin modulation dysfunction exists in patients with TRD. Some polymorphisms in the promoter region of the serotonin transporter gene (SLC6A4) are likely to be involved in the pathogenesis/treatment of MDD; however, no data are available concerning TRD.Therefore, in order to investigate the possible influence of SLC6A4 polymorphisms on the risk of TRD, we genotyped 310 DSM-IV MDD treatment-resistant patients and 284 healthy volunteers. We analysed the most studied polymorphism 5-HTTLPR (L/S) and a single nucleotide substitution, rs25531 (A/G), in relation to different functional haplotype combinations. However the correct mapping of rs25531 is still debated whether it is within or outside the insertion. Our sequencing analysis showed that rs25531 is immediately outside of the 5-HTTLPR segment.Differences in 5-HTTLPR allele (p=0.04) and in L allele carriers (pALA homozygote haplotype was more represented among the control subjects (p=0.01, OR=0.64 95%CI: 0.45-0.91).In conclusion, this study reports a protective effect of the LALA haplotype on TRD, supporting the hypothesis that lower serotonin transporter transcription alleles are correlated to a common resistant depression mechanism.

KW - 5-HTTLPR

KW - Rs25531

KW - SLC6A4

KW - Treatment-resistant depression

UR - http://www.scopus.com/inward/record.url?scp=77955057575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955057575&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2010.04.020

DO - 10.1016/j.pnpbp.2010.04.020

M3 - Article

AN - SCOPUS:77955057575

VL - 34

SP - 367

EP - 370

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

IS - 6

ER -